Company Filing History:
Years Active: 2017-2021
Title: The Innovations of Trent E Balius
Introduction
Trent E Balius is a notable inventor based in Stony Brook, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit the activity of Fatty Acid Binding Proteins (FABPs). With a total of three patents to his name, his work has implications for various therapeutic applications.
Latest Patents
One of his latest patents focuses on α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof. This invention provides a compound and method for inhibiting the activity of FABP by contacting the FABP with a specific compound structure. This innovative approach has the potential to advance treatment options in the pharmaceutical industry.
Career Highlights
Trent E Balius is affiliated with the State University of New York, where he continues to engage in research and development. His academic background and ongoing work contribute to the advancement of knowledge in his field. His dedication to innovation is evident through his patent filings and research endeavors.
Collaborations
Trent has collaborated with esteemed colleagues such as Iwao Ojima and Dale Deutsch. These partnerships have likely enhanced the scope and impact of his research, fostering an environment of shared knowledge and innovation.
Conclusion
Trent E Balius exemplifies the spirit of innovation in the pharmaceutical field through his patents and collaborative efforts. His work on α- and γ-truxillic acid derivatives showcases his commitment to advancing medical science.